Schwere Pneumokokkeninfektionen im Alter – impfpräventabel
Authors:
- 20 December 2012
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 46 (2) , 160-166
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosisVaccine, 2011
- The Capsular Serotype ofStreptococcus pneumoniaeIs More Important than the Genetic Background for Resistance to ComplementInfection and Immunity, 2010
- Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]Drugs, 2010
- Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of ageClinical Microbiology and Infection, 2009
- Vaccines for Older AdultsThe Consultant Pharmacist, 2009
- Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniaeClinical Microbiology and Infection, 2009
- Pneumokokkenimpfung: Konjugatimpfstoff induziert Herdenimmunität und reduziert AntibiotikaresistenzDMW - Deutsche Medizinische Wochenschrift, 2008
- Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study*Critical Care Medicine, 2006
- Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 StudyClinical Infectious Diseases, 2006
- An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical OutcomeClinical Infectious Diseases, 2003